Sign inJoin waitlistJoin the waitlist

Charalambos Andreadis

Professor of Clinical Medicine · University of California (San Francisco) School of Medicine

Credentials: · · · · · ·

History

University of California (San Francisco) School of Medicine
Present

Hematology and Medical Oncology
Hospital of the University of Pennsylvania
2001–2004
Internal Medicine
New York Presbyterian Hospital
1998–2001
Columbia Univ Coll of Phys & Surgeons
1994–1998
Oberlin College, Oberlin, OH
1989–1993

Research

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
New England Journal of Medicine · 2019 · 3,379 citations
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
The Lancet · 2020 · 2,058 citations
ATP citrate lyase inhibition can suppress tumor cell growth
Cancer Cell · 2005 · 852 citations

Stephen Schuster
23 papers
Rebecca Olin
17 papers · 2 as a fellow
Gabriel Mannis
13 papers · 2 as a fellow
Lloyd Damon
13 papers
Thomas Martin
13 papers
Aaron Logan
12 papers
Joseph McGuirk
12 papers
Weiyun Ai
12 papers
DT
Donald Tsai
10 papers
Karin Gaensler
10 papers
Edward Stadtmauer
9 papers
Lawrence Kaplan
9 papers

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $6.5M · University of California, San Francisco
1999–2028
Targeting the c-Met/HGF Axis in Acute Myeloid Leukemia
National Cancer Institute · R03
Contact PI · $158.3K · University of California, San Francisco
2014–2018

Clinical trials

Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Principal investigator · Active not recruiting · Phase 3
National Cancer Institute (NCI)
2016–2026
Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Principal investigator · Completed · Phase 1
University of California, San Francisco
2015–2021
Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML
Principal investigator · Terminated · Phase 1
C. Babis Andreadis
2015–2019
Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Principal investigator · Completed · Phase 2
C. Babis Andreadis
2012–2021